{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:50:05Z","timestamp":1790394605423,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["848015003"],"award-info":[{"award-number":["848015003"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zambon Netherlands BV"},{"name":"Foundation for Clinical Research of the Slotervaart Hospital"},{"name":"Spaarne Gasthuis Academy"},{"name":"Amsterdam Gastroenterology Endocrinology Metabolism"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Patients who undergo bariatric surgery are at risk for developing cholesterol gallstones. We aimed to identify risk factors that are associated with symptomatic gallstone disease and gallstone formation after bariatric surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>We included participants of the UPGRADE trial, a multicenter randomized placebo-controlled trial on the prevention of symptomatic gallstone disease with ursodeoxycholic acid (UDCA) after bariatric surgery. The association between patient characteristics and symptomatic gallstone disease, and gallstone formation was evaluated using logistic regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 959 patients, 78 (8%) developed symptomatic gallstone disease within 24\u00a0months. Risk factors were the presence of a pain syndrome (OR 2.07; 95% CI 1.03 to 4.17) and asymptomatic gallstones before surgery (OR 3.15; 95% CI 1.87 to 5.33). Advanced age (OR 0.95; 95% CI 0.93 to 0.97) was protective, and UDCA prophylaxis did not reach statistical significance (OR 0.64; 95% CI 0.39 to 1.03). No risk factors were identified for gallstone formation, whereas advanced age (OR 0.98; 95% CI 0.96 to 1.00), statin use (OR 0.42; 95% CI 0.20 to 0.90), and UDCA prophylaxis (OR 0.47; 95% CI 0.30 to 0.73) all reduced the risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Young patients with a preoperative pain syndrome and\/or asymptomatic gallstones before bariatric surgery are at increased risk for symptomatic gallstone disease after surgery. Whether statins, either alone or in combination with UDCA prophylaxis, can further reduce the burden of gallstones after bariatric surgery should be investigated prospectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s11695-022-05947-8","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T04:02:51Z","timestamp":1644465771000},"page":"1270-1278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Risk Factors for Symptomatic Gallstone Disease and Gallstone Formation After Bariatric Surgery"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7668-9164","authenticated-orcid":false,"given":"Sylke","family":"Haal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimoena S. S.","family":"Guman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd","family":"Bruin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben N.","family":"van Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fockens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel G. W.","family":"Dijkgraaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Hutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E. A.","family":"Gerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier P.","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"issue":"9531","key":"5947_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0140-6736(06)69044-2","volume":"368","author":"P Portincasa","year":"2006","unstructured":"Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368(9531):230\u20139.","journal-title":"Lancet."},{"issue":"5","key":"5947_CR2","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s11695-015-1858-5","volume":"26","author":"LB Adams","year":"2016","unstructured":"Adams LB, Chang C, Pope J, et al. Randomized, prospective comparison of ursodeoxycholic acid for the prevention of gallstones after sleeve gastrectomy. Obes Surg. 2016;26(5):990\u20134.","journal-title":"Obes Surg."},{"issue":"6","key":"5947_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.soard.2019.03.028","volume":"15","author":"TM Nabil","year":"2019","unstructured":"Nabil TM, Khalil AH, Gamal K. Effect of oral ursodeoxycholic acid on cholelithiasis following laparoscopic sleeve gastrectomy for morbid obesity. Surg Obes Relat Dis. 2019;15(6):827\u201331.","journal-title":"Surg Obes Relat Dis."},{"issue":"4","key":"5947_CR4","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s13304-020-00850-2","volume":"72","author":"N Sakran","year":"2020","unstructured":"Sakran N, Dar R, Assalia A, et al. The use of Ursolit for gallstone prophylaxis following bariatric surgery: a randomized-controlled trial. Updates Surg. 2020;72(4):1125\u201333.","journal-title":"Updates Surg."},{"issue":"7","key":"5947_CR5","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.soard.2018.03.028","volume":"14","author":"MS Altieri","year":"2018","unstructured":"Altieri MS, Yang J, Nie L, et al. Incidence of cholecystectomy after bariatric surgery. Surg Obes Relat Dis. 2018;14(7):992\u20136.","journal-title":"Surg Obes Relat Dis."},{"issue":"4","key":"5947_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.soard.2016.11.022","volume":"13","author":"M Coupaye","year":"2017","unstructured":"Coupaye M, Calabrese D, Sami O, et al. Evaluation of incidence of cholelithiasis after bariatric surgery in subjects treated or not treated with ursodeoxycholic acid. Surg Obes Relat Dis. 2017;13(4):681\u20135.","journal-title":"Surg Obes Relat Dis."},{"issue":"4","key":"5947_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.soard.2007.02.006","volume":"3","author":"DD Portenier","year":"2007","unstructured":"Portenier DD, Grant JP, Blackwood HS, et al. Expectant management of the asymptomatic gallbladder at Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3(4):476\u20139.","journal-title":"Surg Obes Relat Dis."},{"key":"5947_CR8","doi-asserted-by":"publisher","first-page":"559064","DOI":"10.3389\/fsurg.2020.559064","volume":"7","author":"MA Aldriweesh","year":"2020","unstructured":"Aldriweesh MA, Aljahdali GL, Shafaay EA, et al. The incidence and risk factors of cholelithiasis development after bariatric surgery in saudi arabia: a two-center retrospective cohort study. Front Surg. 2020;7:559064.","journal-title":"Front Surg."},{"issue":"2","key":"5947_CR9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/sjg.SJG_472_19","volume":"26","author":"FA Alsaif","year":"2020","unstructured":"Alsaif FA, Alabdullatif FS, Aldegaither MK, et al. Incidence of symptomatic cholelithiasis after laparoscopic sleeve gastrectomy and its association with rapid weight loss. Saudi J Gastroenterol. 2020;26(2):94\u20138.","journal-title":"Saudi J Gastroenterol."},{"issue":"8","key":"5947_CR10","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1007\/s11695-019-03862-z","volume":"29","author":"M Coupaye","year":"2019","unstructured":"Coupaye M, Calabrese D, Sami O, et al. Effectiveness of ursodeoxycholic acid in the prevention of cholelithiasis after sleeve gastrectomy. Obes Surg. 2019;29(8):2464\u20139.","journal-title":"Obes Surg."},{"issue":"4","key":"5947_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.soard.2014.10.015","volume":"11","author":"M Coupaye","year":"2015","unstructured":"Coupaye M, Castel B, Sami O, et al. Comparison of the incidence of cholelithiasis after sleeve gastrectomy and Roux-en-Y gastric bypass in obese patients: a prospective study. Surg Obes Relat Dis. 2015;11(4):779\u201384.","journal-title":"Surg Obes Relat Dis."},{"issue":"4","key":"5947_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1381\/096089203322190862","volume":"13","author":"C de IgleziasBrandao Oliveira","year":"2003","unstructured":"de IgleziasBrandao Oliveira C, Adami Chaim E, da Silva BB. Impact of rapid weight reduction on risk of cholelithiasis after bariatric surgery. Obes Surg. 2003;13(4):625\u20138.","journal-title":"Obes Surg."},{"issue":"7","key":"5947_CR13","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1007\/s00464-008-0204-6","volume":"23","author":"VK Li","year":"2009","unstructured":"Li VK, Pulido N, Fajnwaks P, et al. Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc. 2009;23(7):1640\u20134.","journal-title":"Surg Endosc."},{"issue":"1","key":"5947_CR14","doi-asserted-by":"publisher","first-page":"e20190010000009","DOI":"10.1590\/s0102-865020190010000009","volume":"34","author":"FHF Machado","year":"2019","unstructured":"Machado FHF, Castro Filho HF, Babadopulos R, et al. Ursodeoxycholic acid in the prevention of gallstones in patients subjected to Roux-en-Y gastric bypass1. Acta Cir Bras. 2019;34(1):e20190010000009.","journal-title":"Acta Cir Bras."},{"issue":"7","key":"5947_CR15","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s11695-014-1529-y","volume":"25","author":"A Melmer","year":"2015","unstructured":"Melmer A, Sturm W, Kuhnert B, et al. Incidence of gallstone formation and cholecystectomy 10 years After Bariatric Surgery. Obes Surg. 2015;25(7):1171\u20136.","journal-title":"Obes Surg."},{"issue":"10","key":"5947_CR16","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1007\/s11695-012-0710-4","volume":"22","author":"R Nagem","year":"2012","unstructured":"Nagem R, Lazaro-da-Silva A. Cholecystolithiasis after gastric bypass: a clinical, biochemical, and ultrasonographic 3-year follow-up study. Obes Surg. 2012;22(10):1594\u20139.","journal-title":"Obes Surg."},{"issue":"11","key":"5947_CR17","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1007\/s11695-020-04801-z","volume":"30","author":"F Pizza","year":"2020","unstructured":"Pizza F, D\u2019Antonio D, Lucido FS, et al. The role of ursodeoxycholic acid (UDCA) in cholelithiasis management after one anastomosis gastric bypass (OAGB) for morbid obesity: results of a monocentric randomized controlled trial. Obes Surg. 2020;30(11):4315\u201324.","journal-title":"Obes Surg."},{"issue":"10","key":"5947_CR18","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.soard.2019.06.040","volume":"15","author":"A Rottenstreich","year":"2019","unstructured":"Rottenstreich A, Kleinstern G, Levin G, et al. Does pregnancy increase the risk of cholecystectomy following bariatric surgery? A cross-sectional cohort study. Surg Obes Relat Dis. 2019;15(10):1822\u20138.","journal-title":"Surg Obes Relat Dis."},{"issue":"12","key":"5947_CR19","doi-asserted-by":"publisher","first-page":"5331","DOI":"10.1007\/s00464-019-07323-7","volume":"34","author":"A Talha","year":"2020","unstructured":"Talha A, Abdelbaki T, Farouk A, et al. Cholelithiasis after bariatric surgery, incidence, and prophylaxis: randomized controlled trial. Surg Endosc. 2020;34(12):5331\u20137.","journal-title":"Surg Endosc."},{"issue":"2","key":"5947_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1381\/096089204322857573","volume":"14","author":"L Villegas","year":"2004","unstructured":"Villegas L, Schneider B, Provost D, et al. Is routine cholecystectomy required during laparoscopic gastric bypass? Obes Surg. 2004;14(2):206\u201311.","journal-title":"Obes Surg."},{"issue":"1","key":"5947_CR21","first-page":"33","volume":"83","author":"A Vural","year":"2020","unstructured":"Vural A, Goksu K, Kahraman AN, et al. Increased gallstone formation after sleeve gastrectomy and the preventive role of ursodeoxycholic acid. Acta Gastroenterol Belg. 2020;83(1):33\u20138.","journal-title":"Acta Gastroenterol Belg."},{"issue":"10","key":"5947_CR22","first-page":"1705","volume":"88","author":"LJ Worobetz","year":"1993","unstructured":"Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol. 1993;88(10):1705\u201310.","journal-title":"Am J Gastroenterol."},{"issue":"7","key":"5947_CR23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00595-016-1446-x","volume":"47","author":"E Abdallah","year":"2017","unstructured":"Abdallah E, Emile SH, Elfeki H, et al. Role of ursodeoxycholic acid in the prevention of gallstone formation after laparoscopic sleeve gastrectomy. Surg Today. 2017;47(7):844\u201350.","journal-title":"Surg Today."},{"key":"5947_CR24","doi-asserted-by":"crossref","unstructured":"Alimo\u011fullar\u0131 M, Bulu\u015f H. Predictive factors of gallstone formation after sleeve gastrectomy: a multivariate analysis of risk factors. Surg Today.\u00a02020;50(9):1002-1007.","DOI":"10.1007\/s00595-020-01971-2"},{"issue":"4","key":"5947_CR25","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s11695-015-1815-3","volume":"26","author":"E Cazzo","year":"2016","unstructured":"Cazzo E, Gestic MA, Utrini MP, et al. Influence of insulin resistance status on the development of gallstones following roux-en-y gastric bypass: a prospective cohort study. Obes Surg. 2016;26(4):769\u201375.","journal-title":"Obes Surg."},{"issue":"9","key":"5947_CR26","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.soard.2015.11.004","volume":"12","author":"J Chang","year":"2016","unstructured":"Chang J, Corcelles R, Boules M, et al. Predictive factors of biliary complications after bariatric surgery. Surg Obes Relat Dis. 2016;12(9):1706\u201310.","journal-title":"Surg Obes Relat Dis."},{"issue":"9","key":"5947_CR27","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1007\/s11605-011-1617-4","volume":"15","author":"M D'Hondt","year":"2011","unstructured":"D\u2019Hondt M, Sergeant G, Deylgat B, et al. Prophylactic cholecystectomy, a mandatory step in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass? J Gastrointest Surg. 2011;15(9):1532\u20136.","journal-title":"J Gastrointest Surg."},{"issue":"7","key":"5947_CR28","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.soard.2016.01.029","volume":"12","author":"H Dakour Aridi","year":"2016","unstructured":"Dakour Aridi H, Sultanem S, Abtar H, et al. Management of gallbladder disease after sleeve gastrectomy in a selected Lebanese population. Surg Obes Relat Dis. 2016;12(7):1300\u20134.","journal-title":"Surg Obes Relat Dis."},{"issue":"7","key":"5947_CR29","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1007\/s11695-019-03760-4","volume":"29","author":"HM Guzm\u00e1n","year":"2019","unstructured":"Guzm\u00e1n HM, Sep\u00falveda M, Rosso N, et al. Incidence and risk factors for cholelithiasis after bariatric surgery. Obes Surg. 2019;29(7):2110\u20134.","journal-title":"Obes Surg."},{"issue":"2","key":"5947_CR30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11695-019-04166-y","volume":"30","author":"S Haal","year":"2020","unstructured":"Haal S, Rondagh D, Hutten BA, et al. Risk factors for cholecystectomy after laparoscopic Roux-En-Y gastric bypass. Obes Surg. 2020;30(2):507\u201314.","journal-title":"Obes Surg."},{"issue":"3","key":"5947_CR31","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.soard.2017.11.015","volume":"14","author":"YY Juo","year":"2018","unstructured":"Juo YY, Khrucharoen U, Chen Y, et al. Cost analysis and risk factors for interval cholecystectomy after bariatric surgery: a national study. Surg Obes Relat Dis. 2018;14(3):368\u201374.","journal-title":"Surg Obes Relat Dis."},{"key":"5947_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijsu.2016.03.060","volume":"30","author":"W Manatsathit","year":"2016","unstructured":"Manatsathit W, Leelasincharoen P, Al-Hamid H, et al. The incidence of cholelithiasis after sleeve gastrectomy and its association with weight loss: a two-centre retrospective cohort study. Int J Surg. 2016;30:13\u20138.","journal-title":"Int J Surg."},{"issue":"10","key":"5947_CR33","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1007\/s11695-019-03946-w","volume":"29","author":"S \u00d6zda\u015f","year":"2019","unstructured":"\u00d6zda\u015f S, Bozkurt H. Factors affecting the development of gallstones following laparoscopic sleeve gastrectomy. Obes Surg. 2019;29(10):3174\u20138.","journal-title":"Obes Surg."},{"issue":"3","key":"5947_CR34","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s11695-019-04366-6","volume":"30","author":"MA Sneineh","year":"2020","unstructured":"Sneineh MA, Harel L, Elnasasra A, et al. Increased Incidence of symptomatic cholelithiasis after bariatric Roux-En-Y Gastric bypass and previous bariatric surgery: a single center experience. Obes Surg. 2020;30(3):846\u201350.","journal-title":"Obes Surg."},{"issue":"12","key":"5947_CR35","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1007\/s11695-011-0495-x","volume":"21","author":"I Tarantino","year":"2011","unstructured":"Tarantino I, Warschkow R, Steffen T, et al. Is routine cholecystectomy justified in severely obese patients undergoing a laparoscopic Roux-en-Y gastric bypass procedure? A comparative cohort study. Obes Surg. 2011;21(12):1870\u20138.","journal-title":"Obes Surg."},{"issue":"2","key":"5947_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.soard.2013.10.011","volume":"10","author":"VB Tsirline","year":"2014","unstructured":"Tsirline VB, Keilani ZM, El Djouzi S, et al. How frequently and when do patients undergo cholecystectomy after bariatric surgery? Surg Obes Relat Dis. 2014;10(2):313\u201321.","journal-title":"Surg Obes Relat Dis."},{"issue":"6","key":"5947_CR37","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.soard.2016.12.004","volume":"13","author":"V Wanjura","year":"2017","unstructured":"Wanjura V, Sandblom G, \u00d6sterberg J, et al. Cholecystectomy after gastric bypass-incidence and complications. Surg Obes Relat Dis. 2017;13(6):979\u201387.","journal-title":"Surg Obes Relat Dis."},{"issue":"12","key":"5947_CR38","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1007\/s00268-016-3639-2","volume":"40","author":"M Morais","year":"2016","unstructured":"Morais M, Faria G, Preto J, Costa-Maia J. Gallstones and bariatric surgery: to treat or not to treat? World J Surg. 2016;40(12):2904\u201310.","journal-title":"World J Surg."},{"issue":"8","key":"5947_CR39","first-page":"1000","volume":"86","author":"ML Shiffman","year":"1991","unstructured":"Shiffman ML, Sugerman HJ, Kellum JM, et al. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol. 1991;86(8):1000\u20135.","journal-title":"Am J Gastroenterol."},{"issue":"1","key":"5947_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12876-017-0674-x","volume":"17","author":"TCC Boerlage","year":"2017","unstructured":"Boerlage TCC, Haal S, de Brauw LM, et al. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial). BMC Gastroenterol. 2017;17(1):164.","journal-title":"BMC Gastroenterol."},{"issue":"12","key":"5947_CR41","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/S2468-1253(21)00301-0","volume":"6","author":"S Haal","year":"2021","unstructured":"Haal S, Guman MSS, Boerlage TCC, et al. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial. Lancet Gastroenterol Hepatol. 2021;6(12):993\u20131001.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"5947_CR42","unstructured":"Castor EDC. Castor electronic data capture 2019 [27 Aug. 2019]. Available from: https:\/\/castoredc.com."},{"issue":"7404","key":"5947_CR43","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","volume":"326","author":"MR Law","year":"2003","unstructured":"Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 2003;326(7404):1423.","journal-title":"BMJ."},{"issue":"1","key":"5947_CR44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/jsre.2001.6322","volume":"102","author":"LJ Wudel Jr","year":"2002","unstructured":"Wudel LJ Jr, Wright JK, Debelak JP, et al. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res. 2002;102(1):50\u20136.","journal-title":"J Surg Res."},{"key":"5947_CR45","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Bmj. 2015;350:g7594.","journal-title":"Bmj."}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-05947-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-022-05947-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-05947-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T02:58:27Z","timestamp":1700189907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-022-05947-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["5947"],"URL":"https:\/\/doi.org\/10.1007\/s11695-022-05947-8","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"assertion":[{"value":"3 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}